Stock Update (NYSE:PFE): Pfizer Acquires Treerly and Its Family of Products from Sirio Pharma

[Business Wire] – SHANGHAI–(BUSINESSWIRE)– Pfizer Inc. (NYSE:PFE – News) announced today that it has acquired Sirio Pharma Co. Ltd.’s wholly-owned subsidiary, Treerly Health Co., Ltd., and its family of Treerly products. Treerly is one of the top healthcare brands in China’s retail channel and consists of an extensive portfolio of products uniquely designed to meet women’s nutritional healthcare needs throughout their lives. The Treerly portfolio complements Pfizer Consumer Healthcare’s product portfolio in China and will strengthen its position as a leading provider of over-the-counter (OTC) dietary supplements. Read more on this. Pfizer Inc. (PFE) , valued at $187.49B, began trading this morning at $31.13. Looking at today’s market, PFE one day range is $30.27 to $31.28 with a trailing 52-week range being $28.47 to $36.46. PFE shares are currently priced at 14.22x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s -3.59x forward p/e ratio. The company pays shareholders $1.20 per share annually in dividends, yielding 3.87%. According to a consensus of 16 analysts, the earnings estimate of $0.52 per share would be $0.02 worse than the year-ago quarter and a $0.01 sequential increase. In looking at the bigger picture, the full-year EPS estimate of $2.18 would be a $0.08 setback when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $13.54 Billion. If realized, that would be a 3.28% increase over the year-ago quarter. More recently, Sun Trust Rbsn Humphrey upgraded PFE from Reduce to Neutral (Nov 25, 2015). Previously, Morgan Stanley upgraded PFE from Equal-Weight to Overweight. With the above information in mind, readers should note that the average price target is $40.56, which is 30.29% above where the stock opened this morning. See more in (NYSE:PFE) Similar Articles: Company Update: Pfizer Inc (NYSE:PFE) – Pfizer Announces Collaboration with GSK on Next-Generation Design of Portable, Continuous, Miniature and Modular (PCMM) Oral Solid Dose Development and Manufacturing Units Market Update (NYSE:PFE): Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference Company Update: Pfizer Inc (NYSE:PFE) – Pfizer wins EU approval for $15 bln Hospira buy